I dont think it will happen until the FDA agree on end points, and all indications are stated. When it does NEU should go very strong on pushing their portfolio. Plenty of PR / media with explicit demonstrations on what Daybue has acheived in outcomes and what NZ2591 can do for so many indications. With minimal, if any, side affects. I dont see a low US$ being a showstopper. Companies need pipelines. Their timelines are long.
.
NEU Price at posting:
$12.13 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)